Actively Recruiting
Developing FAPI PET and MRI Imaging as Non-Invasive Tools to Detect and Monitor Lung Fibrosis
Led by University of Wisconsin, Madison · Updated on 2026-10-01
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of a radioactive tracer called fibroblast activation protein inhibitor FAPI combined with PETMRI imaging to non-invasively detect and monitor fibrogenesis, the process leading to fibrosis and scarring in lung tissue. The study focuses on people with fibrotic lung diseases such as fibrotic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. This is a phase 2 clinical trial aiming to better understand how FAPI binds to affected lung cells and how that might improve diagnosis and tracking of disease activity. Participants will be divided into groups undergoing different numbers of PETMRI scans using the FAPI tracer. One group will have three scans during three research visits, each lasting up to 2.5 hours. Another group will have two scans during two visits, and a crossover group will have two additional scans during two more visits. The radioactive tracer is injected into the arm before imaging. The imaging sessions use PET to capture inside body pictures and MRI to assess lung tissue. During the trial, participants will attend research visits for PETMRI scans and evaluations of disease activity. The main outcome measured is the change in FAPI uptake between the first scan and six months later, which may indicate disease progression or treatment effects. Participants must be able to undergo PETMRI without intravenous sedation, and those requiring mild oral anxiolytics can participate under certain conditions. The study lasts until September 2027, with data collected to improve non-invasive fibrosis assessment.
CONDITIONS
Brief Title
Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
Research Team
R
Radiology Studies
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here